semaglutide antibody Biosimilar KRIBIOLISA Anti-Semaglutide ELISA - Diabetes
Description
A new class of medicines is reshaping how we think about obesity, diabetes, and chronic disease
If it sounds ridiculous, thats because...it is.
Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021
Busy pros craving restorative sleep
Excitingly, researchers are now investigating the possible use of GLP-1 based therapeutics for diseases beyond Type 2 diabetes and obesity
